Log In
Print this Print this

Zyflo CR, zileuton CR

  Manage Alerts
Collapse Summary General Information
Company Chiesi Farmaceutici S.p.A.
DescriptionControlled-release formulation of 5-lipoxygenase inhibitor
Molecular Target
Mechanism of Action5-lipoxygenase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAsthma
Indication DetailsTreat and prevent asthma; Treat and prevent asthma in adults and children 12 years of age or older; Treat asthma
Regulatory Designation
PartnerVansen Pharma Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today